Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001185185-21-000614
Filing Date
2021-05-07
Accepted
2021-05-07 10:10:37
Documents
39
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q amgreat20190930_10q.htm 10-Q 253091
2 EXHIBIT 31.1 ex_246571.htm EX-31.1 8611
3 EXHIBIT 32.1 ex_246572.htm EX-32.1 4256
  Complete submission text file 0001185185-21-000614.txt   1331496

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT aagh-20190930.xml EX-101.INS 108344
5 XBRL TAXONOMY EXTENSION SCHEMA aagh-20190930.xsd EX-101.SCH 17557
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aagh-20190930_cal.xml EX-101.CAL 15870
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aagh-20190930_def.xml EX-101.DEF 88077
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE aagh-20190930_lab.xml EX-101.LAB 144088
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aagh-20190930_pre.xml EX-101.PRE 92060
Mailing Address 1609 W VALLEY BLVD UNIT 338A ALHAMBRA CA 91803
Business Address 1609 W VALLEY BLVD UNIT 338A ALHAMBRA CA 91803 (626) 576-1299
America Great Health (Filer) CIK: 0001098009 (see all company filings)

EIN.: 980178621 | State of Incorp.: CA | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-27873 | Film No.: 21900809
SIC: 2834 Pharmaceutical Preparations